Pseudocomplementary oligonucleotides for targeted gene therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8309356
APP PUB NO 20110086905A1
SERIAL NO

12753016

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and methods for targeted gene therapy are disclosed. Compositions containing double duplex-forming pseudocomplementary oligonucleotides are administered in combination with a donor oligonucleotide that is homologous to a target sequence on a double-stranded DNA molecule in need of repair or replacement. By activating cellular mechanisms involved in DNA synthesis, repair and recombination, the double duplex-forming pseudocomplementary oligonucleotides can introduce one or more mutations at a site of interest by increasing the efficiency of targeted recombination of the donor oligonucleotide. The pseudocomplementary oligonucleotides/donor oligonucleotide compositions may be administered in combination with a second therapeutic agent that enhances access of the pseudocomplementary oligonucleotides and/or the donor oligonucleotide to the target site, an agent that enhances or increases DNA repair or recombination, or an agent that enhances uptake or delivery of the oligonucleotides.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YALE UNIVERSITYTWO WHITNEY AVENUE NEW HAVEN CT 06510

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Glazer, Peter M Gulford, US 22 249

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation